                               SEQUENCE LISTING

<110> CERULEAN PHARMA INC.
 
<120> CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS

<130> T2021-7039WO

<140> PCT/US2013/027125
<141> 2013-02-21

<150> 61/718,603
<151> 2012-10-25

<150> 61/650,825
<151> 2012-05-23

<150> 61/636,180
<151> 2012-04-20

<150> 61/601,944
<151> 2012-02-22

<160> 9     

<170> PatentIn version 3.5

<210> 1
<211> 22
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 1
tcaggttcag ggggaggtgt gg                                                22


<210> 2
<211> 23
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 2
cgactggagc acgaggacac tga                                               23


<210> 3
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 3
cgccgatggg ggtgttctgc                                                   20


<210> 4
<211> 44
<212> RNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 4
cgacuggagc acgaggacac ugacauggac ugaaggagua gaaa                        44


<210> 5
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 5
ctctagagcg actggagcac g                                                 21


<210> 6
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 6
agcccctcta gagtcgcggc                                                   20


<210> 7
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 7
cggttcacca gggtgtcgcc                                                   20


<210> 8
<211> 21
<212> RNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide


<220>
<221> modified_base
<222> (4)..(4)
<223> 2'OMe modified nucleotide

<220>
<221> modified_base
<222> (10)..(10)
<223> 2'OMe modified nucleotide

<220>
<221> modified_base
<222> (14)..(14)
<223> 2'OMe modified nucleotide

<220>
<221> modified_base
<222> (18)..(18)
<223> 2'OMe modified nucleotide

<400> 8
agaucacccu ccuuaaauau u                                                 21


<210> 9
<211> 21
<212> RNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide


<220>
<221> modified_base
<222> (8)..(8)
<223> 2'OMe modified nucleotide

<400> 9
uauuuaagga gggugaucuu u                                                 21


